TOKYO, August 21, 2026 – FUJIFILM Holdings Corporation is pleased to announce that its digital camera “FUJIFILM GFX100RF” and MR Imaging System “ECHELON Synergy ZeroHelium” received the prestigious “Bronze Award,” one of the top honors, at the “IDEA (International Design Excellence Awards) 2026” hosted by the Industrial Designers Society of America (IDSA). In addition, eight products, including instax series of hybrid instant camera and production color printer, were selected as finalists for Gold, Silver and Bronze awards.
The IDEA is an international design award program established in 1980 by the Industrial Designers Society of America (IDSA). It is considered as one of the world’s three major design awards alongside Germany’s “iF Design Award” and “Red Dot Design Award.” The jury reviews entries based on strict criteria including design innovation, user benefits and social impact, and selects Gold, Silver and Bronze award winners. This marks the ten time a Fujifilm product has won one of IDEA's top awards.
Fujifilm will continue to work on creating designs that not only have beautiful appearance but also realize designs that highlight the function of each product and service, thereby creating new product values.
Excluding products that are only available in limited regions.
“FUJIFILM GFX ETERNA 55”
“FUJIFILM PROJECTOR ZUH6000”
instax mini LiPlay＋™
instax WIDE Evo™
“Revoria Press™ PC2120”
- * instax, instax mini LiPlay＋,and instax WIDE Evo are registered trademarks or trademarks of FUJIFILM Corporation.
- * Revoria Press is a registered trademark or trademark of FUJIFILM Business Innovation Corporation.
FUJIFILM Holdings Corporation
Design Strategy Office
E-mail:dgi-101-FH-DSO@fujifilm.com
- * Please note that the contents including the product availability, specification, prices and contacts in this website are current as of the date of the press announcement and may be subject to change without prior notice.
- * This news release is issued by FUJIFILM Holdings Corporation in Japan. Fujifilm makes no representation that products on this news release are commercially available in all countries and regions including the US and EU. Approved uses of healthcare products vary by country and region.